Risk of SARS-CoV-2 Reinfection in Children Within the 12 Months Following Mild COVID-19: Insights From a Survey Study.

Authors:
Di Chiara C; Boracchini R; Cantarutti A; Kakkar F; Oletto A and 3 more

Journal:
Pediatr Infect Dis J

Publication Year: 2024

DOI:
10.1097/INF.0000000000004233

PMCID:
PMC10919262

PMID:
38241645

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Pediatr Infect Dis J

Abbreviation: Pediatr Infect Dis J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Communicable Diseases

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Clinical and Economic Burden of Antibiotic Use Among Pediatric Patients With Varicella Infection in…
Kujawski SA; Casey CS; Haas H and 4 more (2024) - Transparency Score: 3/6
COVID-19 Vaccine Acceptance Among Parents of Children With Multisystem Inflammatory Syndrome in Chi…
Blanchard-Rohner G; Sanchez C; Andre MC and 11 more (2024) - Transparency Score: 3/6
Epidemiology and Clinical Characteristics of Human Metapneumovirus Infections in Hospitalized Child…
Steinberg R; Marty V; Korten I and 3 more (2024) - Transparency Score: 3/6
Trends in Otitis Media Ambulatory Visits in American Indian and Alaska Native Children During the P…
Bressler SS; Bruden D; Hammitt LL and 3 more (2024) - Transparency Score: 3/6
Antibody Persistence After Primary SARS-CoV-2 Infection and Protection Against Future Variants Incl…
Aiano F; Ireland G; Baawuah F and 18 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"The authors have no conflicts of interest to disclose."

Evidence found in paper:

"This work is part of the VERDI project (101045989), which is funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025